Cellyan Biotechnology Co., Ltd
HKPD- Exchange
- Nasdaq
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- SEC CIK
- 0002007702
No open-market purchases or sales by Cellyan Biotechnology Co., Ltd insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $105.8K in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Cellyan Biotechnology Co., Ltd changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 6 | 1 | 2 | −3 |
| Shares | 73.6K | 12.0K | 12.1K | −49.4K (−80.3%) |
| Value | $93.5K | $15.4K | $17.8K | −$60.3K (−77.2%) |
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (1)
Institutions that held Cellyan Biotechnology Co., Ltd at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Clear Street Group Inc. | 12,019 | $17.7K | 0.00% |
Sold out (4)
Institutions that held Cellyan Biotechnology Co., Ltd at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Jane Street Group, LLC | 17,026 | $21.8K |
| Valley National Advisers Inc | 13,000 | $16.0K |
| Two Sigma Securities, LLC | 10,329 | $13.2K |
| Tower Research Capital LLC (TRC) | 312 | $399 |
Not filed for Q3 2025 yet (1)
Institutions that held Cellyan Biotechnology Co., Ltd at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Clear Street LLC | 12,019 | $15.4K |